Zhejiang Nhu Co (SZSE:002001) ROCE % : 24.15% (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Nhu Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Nhu Co's annualized ROCE % for the quarter that ended in Mar. 2025 was 24.15%.

Zhejiang Nhu Co ROCE % Historical Data

The historical data trend for Zhejiang Nhu Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Nhu Co ROCE % Chart

Zhejiang Nhu Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

18.78

20.47

15.60

11.28

20.91

Zhejiang Nhu Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															13.50	19.90	24.73	25.07	24.15

Zhejiang Nhu Co ROCE % Calculation

Zhejiang Nhu Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	7225.762	/	( ( (39156.247 - 6122.394)	+	(42989.132 - 6909.2) )	/ 2 )
	=	7225.762	/	( (33033.853	+	36079.932)	/ 2 )
	=	7225.762	/	34556.8925
	=	20.91 %

Zhejiang Nhu Co's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	8807.552	/	( ( (42989.132 - 6909.2)	+	(43777.419 - 6910.201) )	/ 2 )
	=	8807.552	/	( ( 36079.932	+	36867.218 )	/ 2 )
	=	8807.552	/	36473.575
	=	24.15 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Zhejiang Nhu Co (SZSE:002001) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Nhu Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhejiang Nhu Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Nhu Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Nhu Co Ltd (SZSE:002001) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 418, Xinchang Avenue West Road, Qixing Street, Xinchang County, Zhejiang Province, Shaoxing, CHN, 312500

Website

https://www.cnhu.com

Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.

Executives

Hu Bai Fan	Director
Shi Guan Qun	Directors, Directors, and Executives
Hu Bai Shan	Directors, executives
Cui Xin Rong	Director
Chen Xue Cao	Supervisors
Zhou Gui Yang	Director
Qiu Jin Zhuo	Supervisors
Wang Xue Wen	Directors, executives
Wang Zheng Jiang	Director
Ye Yue Heng	Director
Dong Xiao Fang	Supervisors
Liang Xiao Dong	Supervisors
Zhang Xiao Bo	Supervisors
Wang Xu Lin	Supervisors
Ding Zhong Jun	Director

Zhejiang Nhu Co Headlines

No Headlines